[uam_ad id="317182"]

By Lise Alves, Senior Contributing Reporter

SÃO PAULO, BRAZIL – The National Health Service in Brazil (ANVISA) approved the registration of the first vaccine against dengue fever in the country on Monday. As soon as the entity’s Regulation Chamber determines the value of each dose, the product, produced by French pharmaceutical Sanofi Pasteur, will be authorized to be sold.

According to ANVISA, the first to receive the new vaccine will be private laboratories. Brazil’s federal government will have to assess the cost of the product to see if it will incorporate it to the Subscribe to our Premium Membership Plan. Already Subscribed?